Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Vivacell Biotechnology España

Clinical trials sponsored by Vivacell Biotechnology España, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug etrinabdione tested for leg artery disease Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New drug etrinabdione tested for leg artery disease

Disease control Not yet recruiting

This Phase IIa trial tests the safety and tolerability of a new drug called etrinabdione in 30 adults with peripheral arterial disease (PAD). Participants take the drug twice daily for 12 months, starting with a low dose and possibly moving to a higher dose if safe. Researchers w…

Phase 2 • Sponsor: VivaCell Biotechnology España • Aim: Disease control

Last updated Jun 26, 2026 18:09 UTC